Bal Pharma Limited Stock

Equities

BALPHARMA

INE083D01012

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:49 2024-04-29 am EDT 5-day change 1st Jan Change
101.1 INR +0.96% Intraday chart for Bal Pharma Limited +2.43% +0.64%
Sales 2022 2.81B 33.71M Sales 2023 3.04B 36.46M Capitalization 1.05B 12.59M
Net income 2022 56M 671K Net income 2023 25M 300K EV / Sales 2022 0.93 x
Net Debt 2022 1.01B 12.08M Net Debt 2023 1.26B 15.06M EV / Sales 2023 0.76 x
P/E ratio 2022
29.1 x
P/E ratio 2023
40.8 x
Employees 869
Yield 2022
0.93%
Yield 2023
1.49%
Free-Float 33.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.96%
1 week+2.43%
Current month+10.84%
1 month+10.84%
3 months-18.20%
6 months+17.60%
Current year+0.64%
More quotes
1 week
96.95
Extreme 96.95
102.20
1 month
93.25
Extreme 93.25
105.70
Current year
89.20
Extreme 89.2
132.20
1 year
71.00
Extreme 71
132.20
3 years
63.40
Extreme 63.4
148.50
5 years
24.10
Extreme 24.1
148.50
10 years
24.10
Extreme 24.1
167.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 94-07-31
Director of Finance/CFO - 23-06-01
Compliance Officer - 23-07-16
Members of the board TitleAgeSince
Chief Executive Officer - 94-07-31
Director/Board Member 58 19-06-28
Director/Board Member - 19-09-27
More insiders
Date Price Change Volume
24-04-29 101.1 +0.96% 887
24-04-26 100.2 +1.79% 1,913
24-04-25 98.42 -2.44% 12,167
24-04-24 100.9 -0.20% 935
24-04-23 101.1 +2.37% 2,313

Delayed Quote Bombay S.E., April 29, 2024 at 06:00 am EDT

More quotes
Bal Pharma Limited is a fully integrated pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It is specialized in bulk actives, prescription drugs, generics and pharma intermediates. Its focused therapeutic areas are anti-diabetes, anti-histamine, anti-inflammatory, acne treatment, gastroenterology, cardiology, and dermatology. It offers a range of APIs, which includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment. Its finished formulation products cover dosage forms, such as tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments. The Company offers a range of natural medicine, which includes ANARSHA, ASHWAMED, AYURFINE, AYURFINE FORTE, AYURSULIN, IMMUWIN, LIPIVED, MENOLEAP CAPSULES, MENOLEAP SYRUP, PROLIFE, and BALPRO SYRUP.
More about the company
  1. Stock Market
  2. Equities
  3. BALPHARMA Stock